Geode Capital Management, LLC Verrica Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 449,309 shares of VRCA stock, worth $3.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

449,309

Previous 429,677 4.57%

Holding current value

$3.16 Million

Previous $3.15 Million 15.45%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.74 - $6.81 $93,055 - $133,693	19,632 Added 4.57%	449,309 $2.66 Million
Q4 2023 Feb 13, 2024	BUY	$2.93 - $7.32 $37,758 - $94,332	12,887 Added 3.09%	429,677 $3.15 Million
Q3 2023 Nov 13, 2023	BUY	$3.75 - $7.46 $106,061 - $210,991	28,283 Added 7.28%	416,790 $1.62 Million
Q2 2023 Aug 11, 2023	BUY	$5.32 - $6.79 $1.1 Million - $1.41 Million	207,624 Added 114.78%	388,507 $2.24 Million
Q1 2023 May 15, 2023	BUY	$2.88 - $8.51 $51,609 - $152,499	17,920 Added 11.0%	180,883 $1.18 Million

Q4 2022 Feb 13, 2023	BUY	$2.09 - $3.39 $26,601 - $43,147	12,728 Added 8.47%	162,963 $448,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $63,127 - $125,091	29,091 Added 24.01%	150,235 $438,000
Q2 2022 Aug 12, 2022	SELL	$1.81 - $8.93 $174,219 - $859,548	-96,254 Reduced 44.28%	121,144 $232,000
Q1 2022 May 13, 2022	SELL	$7.59 - $9.49 $3,263 - $4,080	-430 Reduced 0.2%	217,398 $1.76 Million
Q4 2021 Feb 11, 2022	SELL	$9.1 - $13.36 $184,193 - $270,419	-20,241 Reduced 8.5%	217,828 $2 Million
Q3 2021 Nov 12, 2021	BUY	$9.55 - $13.96 $239,599 - $350,242	25,089 Added 11.78%	238,069 $2.98 Million
Q2 2021 Aug 13, 2021	BUY	$9.77 - $15.33 $135,040 - $211,891	13,822 Added 6.94%	212,980 $2.41 Million
Q1 2021 May 12, 2021	BUY	$10.51 - $17.46 $151,259 - $251,284	14,392 Added 7.79%	199,158 $3.02 Million
Q4 2020 Feb 12, 2021	SELL	$7.41 - $12.63 $11,537 - $19,664	-1,557 Reduced 0.84%	184,766 $2.13 Million
Q3 2020 Nov 13, 2020	SELL	$6.16 - $10.3 $68,967 - $115,318	-11,196 Reduced 5.67%	186,323 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$9.02 - $15.12 $157,435 - $263,904	17,454 Added 9.69%	197,519 $2.17 Million
Q1 2020 May 14, 2020	BUY	$7.14 - $16.86 $120,166 - $283,753	16,830 Added 10.31%	180,065 $1.97 Million
Q4 2019 Feb 13, 2020	BUY	$13.08 - $17.43 $255,190 - $340,059	19,510 Added 13.57%	163,235 $2.59 Million
Q3 2019 Nov 12, 2019	BUY	$8.65 - $14.81 $534,578 - $915,272	61,801 Added 75.44%	143,725 $2.12 Million
Q2 2019 Aug 14, 2019	BUY	$7.1 - $11.62 $144,421 - $236,362	20,341 Added 33.03%	81,924 $951,000
Q1 2019 May 14, 2019	BUY	$7.95 - $14.07 $196,182 - $347,205	24,677 Added 66.86%	61,583 $665,000
Q4 2018 Feb 13, 2019	BUY	$6.75 - $16.12 $59,973 - $143,226	8,885 Added 31.71%	36,906 $300,000
Q3 2018 Nov 13, 2018	BUY	$13.94 - $19.88 $390,612 - $557,057	28,021 New	28,021 $455,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

16.2M

Call Options Held

Put Options Held

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $289M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Verrica Pharmaceuticals Inc. Transaction History